scholarly article | Q13442814 |
P50 | author | Joan J Bech-Serra | Q42774321 |
Carlos de Torre | Q57365915 | ||
Rosaura Esteve-Puig | Q60541957 | ||
Juan Angel Recio | Q61820611 | ||
Matias Avila | Q73089673 | ||
Marta López-Fauqued | Q84655265 | ||
P2093 | author name string | Glenn Merlino | |
Elena R García-Trevijano | |||
Francesc Canals | |||
Pedro Andreu-Pérez | |||
Stephan Tenbaum | |||
P2860 | cites work | Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF | Q24298749 |
Regulation of p53 activity through lysine methylation | Q24311514 | ||
A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor | Q24319127 | ||
Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma | Q24685552 | ||
Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues | Q27644429 | ||
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth | Q27659493 | ||
Activation mechanism of the MAP kinase ERK2 by dual phosphorylation | Q27743261 | ||
The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity | Q27931859 | ||
Arginine methylation regulates the p53 response | Q28116284 | ||
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 | ||
Prmt5, which forms distinct homo-oligomers, is a member of the protein-arginine methyltransferase family | Q28142367 | ||
A novel WD repeat protein component of the methylosome binds Sm proteins | Q28213642 | ||
Met, metastasis, motility and more | Q28235183 | ||
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF | Q28251989 | ||
Identification of proteins interacting with the RNAPII FCP1 phosphatase: FCP1 forms a complex with arginine methyltransferase PRMT5 and it is a substrate for PRMT5-mediated methylation | Q28304227 | ||
Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF | Q28474973 | ||
Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate | Q28576088 | ||
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions | Q29547189 | ||
The diverse functions of histone lysine methylation | Q29614523 | ||
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF | Q29616828 | ||
Protein arginine methylation in mammals: who, what, and why | Q29617309 | ||
Arginine methylation an emerging regulator of protein function | Q29617311 | ||
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer | Q29618155 | ||
The RAF proteins take centre stage | Q29620153 | ||
Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription | Q33938819 | ||
Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells | Q33940377 | ||
State of the arg: protein methylation at arginine comes of age. | Q34084396 | ||
Methylthioadenosine. | Q35864131 | ||
The highly conserved skb1 gene encodes a protein that interacts with Shk1, a fission yeast Ste20/PAK homolog | Q35931595 | ||
In vivo and in vitro arginine methylation of RNA-binding proteins | Q36551118 | ||
Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential | Q36605563 | ||
Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway | Q36637883 | ||
Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation | Q37155394 | ||
Increased apoptosis after autoimmune regulator expression in epithelial cells revealed by a combined quantitative proteomics approach. | Q39729662 | ||
Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry | Q39919555 | ||
Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. | Q40149301 | ||
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling | Q40224091 | ||
Post-translational modification of H-Ras is required for activation of, but not for association with, B-Raf | Q41224854 | ||
Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines | Q41253565 | ||
PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells | Q41724415 | ||
Signal transduction through MAP kinase cascades | Q41750250 | ||
CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation | Q41825679 | ||
The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. | Q41895997 | ||
Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5). | Q41927743 | ||
Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor | Q41978360 | ||
NO sensitizes rat hepatocytes to proliferation by modifying S-adenosylmethionine levels | Q43976612 | ||
L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine | Q44378796 | ||
SB203580 promotes EGF-stimulated early morphological differentiation in PC12 cell through activating ERK pathway | Q46107993 | ||
PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation | Q47995280 | ||
Polycomb group protein ezh2 controls actin polymerization and cell signaling. | Q53676862 | ||
PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins | Q56227906 | ||
Control of MAPK signalling: from complexity to what really matters | Q57393852 | ||
Principles behind the multifarious control of signal transduction | Q57393856 | ||
Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation | Q57903814 | ||
P433 | issue | 190 | |
P304 | page(s) | ra58 | |
P577 | publication date | 2011-09-01 | |
P1433 | published in | Science Signaling | Q7433604 |
P1476 | title | Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF | |
P478 | volume | 4 |
Q54371898 | 5'-Methylthioadenosine attenuates ischemia reperfusion injury after liver transplantation in rats. |
Q24306061 | A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation |
Q30364303 | A spatial simulation approach to account for protein structure when identifying non-random somatic mutations |
Q36105914 | Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis |
Q26851594 | Arginine methyltransferases as novel therapeutic targets for breast cancer |
Q36625184 | BDNF-mediated regulation of ethanol consumption requires the activation of the MAP kinase pathway and protein synthesis |
Q41948499 | Cancer biology: Enzyme meets a surprise target |
Q85083770 | Cell signalling: PRMT5 restricts ERK activity |
Q36091672 | Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant Melanoma |
Q35989000 | Cortex Fraxini (Qingpi) Protects Rat Pheochromocytoma Cells against 6-Hydroxydopamine-Induced Apoptosis |
Q52362886 | Cryo-electron microscopy structure of a human PRMT5:MEP50 complex. |
Q27674576 | Crystal structure of the human PRMT5:MEP50 complex |
Q58614576 | Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells |
Q59355907 | Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma |
Q42631580 | Differential regulation of SC1/PRDM4 and PRMT5 mediated protein arginine methylation by the nerve growth factor and the epidermal growth factor in PC12 cells |
Q39549990 | Discovery of a Dual PRMT5-PRMT7 Inhibitor |
Q34271722 | Expanding applications of chemical genetics in signal transduction |
Q33824979 | Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro. |
Q53048996 | Expression of proteins involved in epigenetic regulation in human cutaneous melanoma and peritumoral skin. |
Q50915851 | Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML. |
Q28082123 | Histone methylation modifiers in cellular signaling pathways |
Q38740496 | Inhibitors of Protein Methyltransferases and Demethylases. |
Q35861696 | MAPK feedback encodes a switch and timer for tunable stress adaptation in yeast. |
Q35906658 | Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease |
Q41819199 | Negative feedback self-regulation contributes to robust and high-fidelity transmembrane signal transduction |
Q38285792 | Non-histone protein methylation as a regulator of cellular signalling and function |
Q89640752 | PRMT5 in gene regulation and hematologic malignancies |
Q60921863 | PRMT5 is essential for B cell development and germinal center dynamics |
Q35009896 | PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.). |
Q98222280 | PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation |
Q50019708 | PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma |
Q90458178 | PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease |
Q37295744 | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. |
Q38935888 | Protein arginine methylation/demethylation and cancer |
Q60924996 | Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer |
Q37145814 | Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation |
Q38067063 | Protein arginine methyltransferases and cancer |
Q30002318 | Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells |
Q27438184 | Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system. |
Q35581589 | Role of JMJD6 in Breast Tumourigenesis. |
Q37693442 | Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis |
Q24302471 | Role of type II protein arginine methyltransferase 5 in the regulation of Circadian Per1 gene |
Q38818202 | SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells |
Q38642785 | Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity |
Q37056442 | Small Molecule Inhibitors of Protein Arginine Methyltransferases. |
Q37687428 | Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination |
Q47404539 | Targeting protein arginine methyltransferase 5 in disease |
Q90040743 | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy |
Q35400332 | The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling |
Q51107160 | The Structure and Function of the PRMT5:MEP50 Complex. |
Q38682980 | The winding path of protein methylation research: milestones and new frontiers |
Q24300544 | Transcription factor positive regulatory domain 4 (PRDM4) recruits protein arginine methyltransferase 5 (PRMT5) to mediate histone arginine methylation and control neural stem cell proliferation and differentiation |
Q30431811 | Utilizing protein structure to identify non-random somatic mutations |
Search more.